genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 8.28M |
| Revenue (ttm) | 613.00K |
| Net Income (ttm) | -7.37M |
| Shares Out | 624.90M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,774,799 |
| Average Volume | 1,866,161 |
| Open | 1.311 |
| Previous Close | 1.325 |
| Day's Range | 1.311 - 1.350 |
| 52-Week Range | 1.300 - 5.500 |
| Beta | 0.29 |
| RSI | 34.25 |
| Earnings Date | Nov 28, 2025 |
About genedrive
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides c system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Cl... [Read more]
Financial Performance
In 2024, genedrive's revenue was 501,000, an increase of 810.91% compared to the previous year's 55,000. Losses were -7.08 million, 37.4% more than in 2023.
Financial StatementsNews
Small Cap Stocks: Genedrive, Tern, Conroy Gold
Genedrive, Tern, Mobile Tornado, Conroy Gold, Nativo Resources are today's biggest Small Cap stock movers